New Edge Wealth, LLC Ionis Pharmaceuticals Inc Transaction History

New Edge Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $53,384 - $71,092	-1,461 Reduced 19.97%	5,854 $259,000
Q2 2022 Aug 09, 2022	BUY	$31.71 - $43.0 $231,958 - $314,545	7,315 New	7,315 $271,000
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $284,056 - $388,584	-8,224 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $349,602 - $524,526	8,224 New	8,224 $370,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Wealth, LLC with notifications on news.